Women of reproductive potential should discuss contraception and pregnancy planning with their healthcare team before initiating tirzepatide therapy
According to KFF, a health policy organization, Medicaid in 13 states covers GLP-1s for obesity
Storage: e.g., 20 C (protect from light) Stability: Lyophilized form remains stable when stored under recommended conditions
The evidence base for tirzepatide as monotherapy is robust, with pivotal trials including SURMOUNT-1 demonstrating significant weight reduction in adults with obesity, and SURPASS trials establishing glycemic efficacy in type 2 diabetes
From a satiety perspective, this helps
The GLP-1 friendly options emphasize high-protein, portion-controlled meals designed to support protein goals